SCRIPT cDNA Synthesis Kit
For general laboratory use.
Please centrifuge briefly before opening (volume ≤2 ml).
Description:
SCRIPT cDNA Synthesis Kit contains all reagents required for first strand cDNA synthesis in one box combining simple handling with high flexibility. The premium quality Reverse Transcriptase, ultrapure dNTPs and an optimized reaction buffer ensure superior results with highest reproducibility. The kit is optimized for high efficiency in a broad range of primer-template combinations.
SCRIPT Reverse Transcriptase is a genetically engineered version of M-MLV Reverse Transcriptase (M-MLV RT) with eliminated RNase H activity and increased thermal stability. The enzyme is a RNA-directed DNA polymerase that synthesizes a complementary DNA strand initiating from a primer using single-stranded RNA or DNA as template. Its enhanced thermal stability in combination with the deactivated RNase H activity results in an increased specificity, higher cDNA yield and an improved efficiency for full length cDNA synthesis compared with standard M-MLV RT. The enzyme is recommended for synthesis of cDNA from 100 bp up to 10 kb length.
Activity and stability has been tested in first strand cDNA synthesis.
Shipping: shipped on gel packs
Storage Conditions: store at -20 °C
avoid freeze/thaw cycles
Shelf Life: 12 months
Form: liquid
Applications:
Synthesis of highly structured and long cDNA fragments, extremely sensitive and highly specific RT-PCR, DNA labeling.
Content:
| Component | Cap | PCR-511S | PCR-511L |
|---|---|---|---|
| SCRIPT Reverse Transcriptase 200 units/μl | red | 100 μl | 500 μl |
| SCRIPT RT Buffer complete 5x conc. | green | 400 μl | 2x 1 ml |
| dNTP Mix 10 mM each | white | 100 μl | 500 μl |
| Oligo-(dT)20 primer 100 μM | white | 50 μl | 250 μl |
| Random Hexamers 100 μM | white | 50 μl | 250 μl |
| RNase Inhibitor 40 units/μl | yellow | 50 μl | 250 μl |
| Positive Control RNA 10 ng/μl | blue | 10 μl | 50 μl |
| RNase-free water | white | 1.2 ml | 6 ml |
Recommended protocols for cDNA synthesis:
Sample denaturation is particularly recommended for RNA targets that exhibit a high degree of secondary structure, for self- or cross-complementary primers and for initial experiments with new targets. For many standard combinations of RNA and primers heat treatment may be omitted with no negative effect on results.
1a Assay set-up without sample denaturation
(standard RNA/primer combinations)
Assay preparation
Add the following components to a nuclease-free microtube. Pipett on ice and mix the components by pipetting gently up and down. In general, water, RNA and primers should be mixed together before the remaining components are added.
| component | stock conc. | final conc. | 20 μl assay |
|---|---|---|---|
| RNase-free water | - | - | fill up to 20 μl |
| RNA template | - | total RNA: 10 pg - 5 μg or mRNA: 10pg-500ng | x μl |
| Primer | 100 μM | -gene-specific primer: 10-20 pmol (50-100 ng) -oligo-dT15-25 primer: 50 pmol (300 ng) -random primer: 50 pmol (100 ng) | - 0.1-0.2 μl - 0.5 μl - 0.5 μl |
| SCRIPT RT Buffer complete | 5x | 1x | 4 μl |
| dNTP Mix | 10 mM each | 500 μM each | 1 μl |
| RNase Inhibitor1) | 40 units/μl | 20 units | 0.5 μl |
| SCRIPT Reverse Transcriptase2) | 200 units/μl | 100 units | 0.5 μl |
1)Addition of 20-40 units RNase inhibitor per assay is recommended and may be essential when working with low amounts of starting RNA.
2)100 units (0.5 μl) of enzyme is recommended for standard assays but increasing the amount of enzyme to 200 units (1 μl) per assay may show even higher transcription yields under selected assay conditions.
Continue with step 2 First-strand cDNA synthesis
1b Assay set-up with sample denaturation
(RNA/primer with a high degree of secondary structure)
Preparation of the RNA Template / Primer Mix
Add the following components to a nuclease-free microtube and mix by pipetting gently up and down:
| component | stock conc. | final conc. | 20 μl assay |
|---|---|---|---|
| RNase-free water | - | - | fill up to 10 μl |
| RNA template | - | total RNA: 10 pg - 5 μg or mRNA: 10pg-500ng | x μl |
| Primer | 100 μM | -gene-specific primer: 10-20 pmol (50-100 ng) -oligo-dT15-25 primer: 50 pmol (300 ng) -random primer: 50 pmol (100 ng) | - 0.1-0.2 μl - 0.5 μl - 0.5 μl |
Denaturation and primer annealing
Incubate the mixture at 65-70 °C for 5 min and place it at room temperature (if using specific primer) or on ice (if using oligo-dT or random primer).
Preparation of the Reaction Mix
Add the following components to a further nuclease-free microtube and mix by pipetting gently up and down:
| component | stock conc. | final conc. | 20 μl assay |
|---|---|---|---|
| RNase-free water | - | - | fill up to 10 μl |
| SCRIPT RT Buffer complete | 5x | 1x | 4 μl |
| dNTP Mix | 10 mM each | 500 μM each | 1 μl |
| RNase Inhibitor1) | 40 units/μl | 20 units | 0.5 μl |
| SCRIPT Reverse Transcriptase2) | 200 units/μl | 100 units | 0.5 μl |
1)Addition of 20-40 units RNase inhibitor per assay is recommended and may be essential when working with low amounts of starting RNA.
2)100 units (0.5 μl) of enzyme is recommended for standard assays but increasing the amount of enzyme to 200 units (1 μl) per assay may show even higher transcription yields under selected assay conditions.
Complete Reaction Mix
Add 10 μl Reaction Mix to 10 μl RNA Template / Primer Mix to complete the 20 μl Reaction Mix. Pipett on ice and mix by pipetting gently up and down.
2 First-strand cDNA synthesis
Incubation
Incubate the reaction mix at 50 °C for 30-60 min if using gene-specific primers. If using oligo-dT or random primers incubate at 42 °C for 10 min followed by incubation at 50 °C for 30-60 min.
[Please note: The optimal time depends on the length of cDNA. Incubation of 60 min is recommended for cDNA fragments of more than 2,000 bp length. The optimal temperature depends on the structural features of the RNA. Increase the temperature to 55 °C for difficult templates with high secondary structure. Note that optimal reaction time and temperature should be adjusted for each particular RNA.]
Optional: Heat inactivation
Heat the mixture to 70 °C for 10 min to inactivate the Reverse Transcriptase.
Optional: RNA removal
Add 2 units DNase-free RNase and incubate at 37 °C for 20 min.
The cDNA can now be used as template in PCR or be stored at -20 °C. Apply 2-5 μl of the RT assay for further amplification in PCR.
However, some specific DNA applications may require the prior inactivation of the remaining RTase or the enzymatic removal of RNA.
| Cat. No. | Amount | Price |
|---|---|---|
| PCR-511S | 100 reactions x 20 μl | 227,08 € |
| PCR-511L | 500 reactions x 20 μl | 908,32 € |
At this point, external content from bioz.com is embedded. When it loads, data (e.g. your IP address) is transmitted to the provider.
Scientific citations for Jena Bioscience pcr-511
221 scientific citations and 7 citation images found by Bioz.
-
Trichomonas vaginalis cathepsin D-like aspartic proteinase (Tv-CatD) is regulated by iron at different levels.
Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2026-09-10 · PMID:42720834
.. 2 × 107 PBS‒washed parasites grown under IR and HI conditions using TRIzol (Invitrogen).. cDNA was synthesized using the
SCRIPT cDNA Synthesis Kit (Jena Bioscience ) following the manufacturer’s instructions.. RT‒qPCR was performed using PanGreen Universal SYBR Green Master Mix (Bio-Helix) with 150 ng .. -
Chromatin accessibility classification of TAD boundaries discloses new architectural proteins
Nucleic Acids Research, 2026-09-09 · PMID:42639792
.. treated with RQ1 RNase-free DNase (Promega).The RNAs were treated with RQ1 RNase-free DNase (Promega).. The complementary DNA (cDNA) synthesis were performed with
SCRIPT cDNA Synthesis Kit (Jena Bioscience ).. The OAZ1 gene was used as housekeeping gene calibrator.The OAZ1 gene was used as .. -
The effect of toll like receptors in prognosis in patients undergoing radical cystectomy for bladder cancer.
Molecular Biology Reports, 2026-08-29 · PMID:42667340
Abstract: We aimed to evaluate the prognostic significance of TLR4 expression in bladder cancer, its association with genes related to EMT, and the potential regulatory role of selected microRNAs. Tumor and adjacent healthy bladder tissue samples obtained from 25 patients who underwent radical cystectomy for bladder cancer were analysed. The expression levels of TLR4, SPRR2A, SPRR1A, SPRR2B, ZEB2 and CDH1, in addition to miR-200c-3p and miR-146a-5p were measured using the RT-PCR method
